Sector pending / Hospital and Medical Service PlansUpdated 2026-05-10 22:07 UTC

LON/0R0O stock hub

LON/0R0O has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R0Ois not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

253.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R0O

In the news

Latest news · LON/0R0O

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.2

P25 n/aP50 n/aP75 n/a

Trailing P/E27.8

P25 n/aP50 n/aP75 n/a

ROE12.2

P25 n/aP50 n/aP75 n/a

ROIC9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R0O market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	390,000
Employees Change	-40,000%
Employees Change Percent	-9.09
Enterprise value	$295.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Hospital and Medical Service Plans
Isin	US91324P1021
Last refreshed	2026-05-10
Market cap	$253.2B
Price	$375
Price currency	USD
Rev Per Employee	873,256.16x
Sic	6324
Symbol	lon/0R0O
Website	https://www.unitedhealthgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.6%
EV Earnings	32.38x
EV/EBIT	21.37x
EV/EBITDA	17.45x
EV/FCF	19.83x
EV/Sales	0.89x
FCF yield	5.88%
Forward P/E	20.17x
P/B ratio	3.18x
P/E ratio	27.77x
P/S ratio	0.74x
PE Ratio10 Y	22.25x
PE Ratio3 Y	24.62x
PE Ratio5 Y	24.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.19%
EBITDA Margin	4.77%
FCF margin	4.37%
Gross margin	18.8%
Gross Profit	$64B
Net Income	$9.1B
Net Income Growth	-45.52%
Net Income Growth Q	-0.19%
Net Income Growth3 Y	-16.52%
Net Income Growth5 Y	-6.53%
Pretax Margin	3.24%
Profit Margin	2.68%
Profit Per Employee	$23,387
ROA	3.78
Roa5y	6.76
ROCE	9.49
ROE	12.18
Roe5y	20.42
ROIC	9.01
Roic5y	14.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-32.3%
Cagr3y	-6.93%
Cagr5y	-0.36%
Div CAGR3	6.19%
Div CAGR5	11.45%
EPS Growth	-44.39
EPS Growth Q	0.73
EPS Growth3 Y	-15.37
EPS Growth5 Y	-5.51
FCF Growth	-20.9%
FCF Growth Q	78.79%
FCF Growth3 Y	-16.85%
FCF Growth5 Y	-3.16%
OCF Growth	-18.81%
OCF Growth Q	63.34%
OCF Growth10 Y	8.99%
OCF Growth3 Y	-14.63%
OCF Growth5 Y	-1.71%
Revenue Growth	9.67x
Revenue Growth Q	1.96x
Revenue Growth3 Y	10.21x
Revenue Growth5 Y	11.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.45
Assets	$236.8B
Cash	$23.6B
Debt	$59B
Debt EBITDA	$3.38
Debt Equity	$0.74
Debt FCF	$3.96
Equity	$79.8B
Interest Coverage	4.76
Liabilities	$157B
Net Cash	$-37.8B
Net Cash By Market Cap	$-14.93
Net Debt EBITDA	$2.33
Net Debt Equity	$0.47
Net Debt FCF	$2.54
Tangible Book Value	$-24.8B
Tangible Book Value Per Share	$-27.29
WACC	7.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Net Working Capital	$-33.7B
Quick ratio	0.72
Working Capital	$-17.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.05%
Dividend Growth	0.68%
Dividend Growth Years	9%
Dividend per share	$6.56
Dividend Years	9
Dividend Yield	1.75%
Ex Div Date	2026-03-09
Last Dividend	$1.65
Payout Frequency	Quarterly
Payout Ratio	66.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-32.28%
200-day SMA	317.3
3Y total return	-19.39%
50-day SMA	309.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-1.77%
All Time High	630.1
All Time High Change	-40.42%
All Time High Date	2024-11-11
All Time Low	193.8
All Time Low Change	93.71%
All Time Low Date	2020-03-23
ATR	9.95
Beta	0.65
Ch YTD	13.26
High	375.4
High52	394.5
High52 Date	2025-05-08
High52ch	-4.84%
Low	368
Low52	235
Low52 Date	2025-08-04
Low52ch	59.75%
Ma50ch	21.17%
Price vs 200-day SMA	18.3%
RSI	77.96
RSI Monthly	46.73
RSI Weekly	62.18
Sharpe ratio	0.28x
Sortino ratio	0.46
Total Return	3.8%
Tr YTD	14.15
Tr1m	20.81%
Tr1w	1.34%
Tr3m	36.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$14.3B
Operating margin	4.19

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	900,467,619%
Net Borrowing	-2,629,647,690
Shares Insiders	0.17%
Shares Institutions	83.57%
Shares Qo Q	0%
Shares Yo Y	-2.05%
Short Ratio	1.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$14.2B
Average Volume	14,758.1x
Bv Per Share	81.64
CAPEX	$-2.6B
Ch1m	20.81
Ch1w	1.34
Ch1y	-34.14
Ch3m	35.75
Ch3y	-23.97
Ch5y	-9.8
Ch6m	17.35
Change	2.04%
Change From Open	1.83
Close	367.9
Days Gap	0.2
Dollar Volume	2,232,563.3
Earnings Date	2026-04-21
EBIT	$14.3B
EBITDA	$16.3B
EPS	$10.03
F Score	5
FCF	$14.9B
FCF EV Yield	5.04x
Financing CF	-11,158,889,175
Fiscal Year End	December
Founded	1,974
Goodwill	81,062,099,168
Graham Number	189.65572
Graham Upside	-49.48
Income Tax	$1.3B
Investing CF	-8,374,278,690
Is Primary Listing	0
Last Earnings Date	2026-04-21
Last Report Date	2026-03-31
Lynch Fair Value	$67.6
Lynch Upside	-81.99
Ma150	322
Ma150ch	16.59%
Ma20	349.2
Ma20ch	7.5%
Net CF	-2,056,840,380
Next Earnings Date	2026-07-14
Open	368.7
P FCF Ratio	17
P OCF Ratio	14.44
Payment Date	2026-03-17
Position In Range	99.49
Ppne	7,824,393,838
Price Date	2026-05-08
Price EBITDA	$15.58
Relative Volume	0.4x
Revenue	340,569,903,465x
SBC By Revenue	0.21x
Share Based Comp	714,895,920
Tax By Revenue	0.39x
Tax Rate	11.96%
Tr6m	19.06%
Volume	5,947

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R0O dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$6.56 annual per share

Payout ratio

+66.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.4%

9 consecutive years of growth

Total shareholder yield

+3.8%

Next ex-dividend date: 2026-03-09

Performance

LON/0R0O stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R0O?

Insider, institutional, and short-interest positioning.

Institutional ownership

+83.6%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R0O momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.0

Above 70: short-term overbought

Price vs 200-day MA

+18.3%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R0O

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R0O stock rating?

lon/0R0O is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R0O analysis?

The full report lives at /stocks/lon/0R0O/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R0O?

The latest report frames lon/0R0O around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R0O page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.